These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38015301)

  • 1. Impact of tardive dyskinesia on patients and caregivers: a survey of caregivers in the United States.
    Jain R; Ayyagari R; Goldschmidt D; Zhou M; Finkbeiner S; Leo S
    J Patient Rep Outcomes; 2023 Nov; 7(1):122. PubMed ID: 38015301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Tardive Dyskinesia on Physical, Psychological, Social, and Professional Domains of Patient Lives: A Survey of Patients in the United States.
    Jain R; Ayyagari R; Goldschmidt D; Zhou M; Finkbeiner S; Leo S
    J Clin Psychiatry; 2023 Apr; 84(3):. PubMed ID: 37022752
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of tardive dyskinesia on quality of life in patients with bipolar disorder, major depressive disorder, and schizophrenia.
    McEvoy J; Gandhi SK; Rizio AA; Maher S; Kosinski M; Bjorner JB; Carroll B
    Qual Life Res; 2019 Dec; 28(12):3303-3312. PubMed ID: 31435866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Tardive Dyskinesia Impact Scale (TDIS), a novel patient-reported outcome measure in tardive dyskinesia: development and psychometric validation.
    Farber RH; Stull DE; Witherspoon B; Evans CJ; Yonan C; Bron M; Dhanda R; Jen E; Brien CO'
    J Patient Rep Outcomes; 2024 Jan; 8(1):2. PubMed ID: 38175450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cumulative Burden of Illness in Veterans With Tardive Dyskinesia and Serious Mental Disorders.
    Caroff SN; Leong SH; Roberts C; Berkowitz RM; Campbell EC
    J Clin Psychopharmacol; 2020; 40(1):38-45. PubMed ID: 31834084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The burden of tardive dyskinesia secondary to antipsychotic medication use among patients with mental disorders.
    McEvoy J; Park T; Schilling T; Terasawa E; Ayyagari R; Carroll B
    Curr Med Res Opin; 2019 Jul; 35(7):1205-1214. PubMed ID: 30638073
    [No Abstract]   [Full Text] [Related]  

  • 7. Patient perspective of tardive dyskinesia: results from a social media listening study.
    Farrar M; Lundt L; Franey E; Yonan C
    BMC Psychiatry; 2021 Feb; 21(1):94. PubMed ID: 33588795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determining Whether a Definitive Causal Relationship Exists Between Aripiprazole and Tardive Dyskinesia and/or Dystonia in Patients With Major Depressive Disorder, Part 3: Clinical Trial Data.
    Preskorn SH; Macaluso M
    J Psychiatr Pract; 2016 Mar; 22(2):117-23. PubMed ID: 27138080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caregiver-Reported Burden in RE-KINECT: Data From a Prospective Real-World Tardive Dyskinesia Screening Study.
    Cutler AJ; Caroff SN; Tanner CM; Shalhoub H; Lenderking WR; Pagé V; Franey E; Yonan C
    J Am Psychiatr Nurses Assoc; 2023; 29(5):389-399. PubMed ID: 34154444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tardive dyskinesia among patients using antipsychotic medications in customary clinical care in the United States.
    Loughlin AM; Lin N; Abler V; Carroll B
    PLoS One; 2019; 14(6):e0216044. PubMed ID: 31163035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining utility values for patients with tardive dyskinesia.
    Ayyagari R; Goldschmidt D; Zhou M; Ribalov R; Caroff SN; Leo S
    Curr Med Res Opin; 2022 Mar; 38(3):401-407. PubMed ID: 35045768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RE-KINECT: A Prospective Study of the Presence and Healthcare Burden of Tardive Dyskinesia in Clinical Practice Settings.
    Caroff SN; Yeomans K; Lenderking WR; Cutler AJ; Tanner CM; Shalhoub H; Pagé V; Chen J; Franey E; Yonan C
    J Clin Psychopharmacol; 2020; 40(3):259-268. PubMed ID: 32332461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact-Tardive Dyskinesia (Impact-TD) Scale: A Clinical Tool to Assess the Impact of Tardive Dyskinesia.
    Jackson R; Brams MN; Carlozzi NE; Citrome L; Fritz NE; Hoberg AR; Isaacson SH; Kane JM; Kumar R
    J Clin Psychiatry; 2022 Nov; 84(1):. PubMed ID: 36449471
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of possible tardive dyskinesia on physical wellness and social functioning: results from the real-world RE-KINECT study.
    Tanner CM; Caroff SN; Cutler AJ; Lenderking WR; Shalhoub H; Pagé V; Franey EG; Serbin M; Yonan C
    J Patient Rep Outcomes; 2023 Mar; 7(1):21. PubMed ID: 36892733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Clinical and Economic Burden of Tardive Dyskinesia in Israel: Real-World Data Analysis.
    Barer Y; Ribalov R; Yaari A; Maor R; Arow Q; Logan J; Chodick G; Arkadir D; Eitan R
    J Clin Psychopharmacol; 2022 Sep-Oct 01; 42(5):454-460. PubMed ID: 36018237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determining Whether a Definitive Causal Relationship Exists Between Aripiprazole and Tardive Dyskinesia and/or Dystonia in Patients With Major Depressive Disorder, Part 4: Case Report Data.
    Macaluso M; Flynn A; Preskorn S
    J Psychiatr Pract; 2016 May; 22(3):203-20. PubMed ID: 27123800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of Blood Biochemical Markers with Tardive Dyskinesia in Schizophrenic Patients.
    Wu Q; Yuan F; Zhang S; Liu W; Miao Q; Zheng X; Lu S; Hou K
    Dis Markers; 2022; 2022():1767989. PubMed ID: 35299866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A descriptive analysis of spontaneous reports of antipsychotic-induced tardive dyskinesia and other extrapyramidal symptoms in the Japanese Adverse Drug Event Report database.
    Saga Y; Chiang CL; Wakamatsu A
    Neuropsychopharmacol Rep; 2024 Mar; 44(1):221-226. PubMed ID: 37884014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex difference in association between tardive dyskinesia and cognitive deficits in patients with chronic schizophrenia.
    Zhang W; Wang D; Zhou H; Chen D; Xiu M; Cui L; Zhang X
    Schizophr Res; 2023 May; 255():140-147. PubMed ID: 36989671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tardive Dyskinesia Prevalence in the Period of Second-Generation Antipsychotic Use: A Meta-Analysis.
    Carbon M; Hsieh CH; Kane JM; Correll CU
    J Clin Psychiatry; 2017 Mar; 78(3):e264-e278. PubMed ID: 28146614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.